Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis
Katie A Parsels, Robert W. Seabury, Stephanie Zyck, Christopher D. Miller, Satish Krishnamurthy, William Darko, Luke A. Probst, Julius Gene Latorre, Gregory M. Cwikla, Elizabeth A. Feldman
Topics & Concepts
MedicineRivaroxabanApixabanHemostasisRetrospective cohort studyProthrombin complex concentrateSingle CenterCohortIntracerebral hemorrhageInternal medicineAnesthesiaSurgeryWarfarinSubarachnoid hemorrhageAtrial fibrillationIntracerebral and Subarachnoid Hemorrhage ResearchAtrial Fibrillation Management and OutcomesTrauma, Hemostasis, Coagulopathy, Resuscitation